MoneyWorks4Me

Eiko Lifesciences - Quaterly Results

17 Jan 2023 Evaluate
A decrease in the sales to Rs. 43.76 millions was observed for the quarter ended December 2022. The sales stood at Rs. 55.80 millions during the similar quarter previous year.The Total Profit for the quarter ended December 2022 of Rs. 2.56 millions grew from Rs.-0.60 millionsOP of the company witnessed a marginal growth to 5.12 millions from 2.02 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 43.76 55.80 -21.58 117.27 201.19 -41.71 254.12 119.91 111.93
Other Income 1.86 1.47 26.53 6.47 4.67 38.54 6.73 4.60 46.30
PBIDT 5.12 2.02 153.47 12.40 15.17 -18.26 19.68 9.83 100.20
Interest 0.13 1.27 -89.76 1.16 3.59 -67.69 4.64 0.88 427.27
PBDT 4.99 0.75 565.33 11.24 11.58 -2.94 15.04 8.95 68.04
Depreciation 1.58 1.53 3.27 4.73 4.07 16.22 5.62 0.62 806.45
PBT 3.41 -0.78 -537.18 6.51 7.51 -13.32 9.42 8.33 13.09
TAX 0.85 -0.18 -572.22 1.62 1.91 -15.18 2.36 2.19 7.76
Deferred Tax 0.85 0.58 46.55 1.62 1.88 -13.83 2.34 -0.03 -7900.00
PAT 2.56 -0.60 -526.67 4.89 5.60 -12.68 7.06 6.14 14.98
Equity 83.16 83.16 0.00 83.16 83.16 0.00 83.16 38.20 117.70
PBIDTM(%) 11.70 3.62 223.20 10.57 7.54 40.24 7.74 8.20 -5.53
Peers
Company Name CMP
Godrej Industries 1021.20
SRF 2490.00
BASF India 3411.40
Pidilite Inds. 1470.00
Tata Chemicals 607.90
View more..